Methods for promoting production of myelin by Schwann cells
US6569419B2 · kind B2 · utility
3Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 2001 |
| Grant date | May 27, 2003 |
| Priority date | — |
| Expiry date | Feb 27, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for promoting the expression of myelin or Protein Zero in Schwann cells using Zcyto7 or IL-17. Zcyto7 or IL-17 are further used to promote myelination of the peripheral nervous system. This is particularly useful in treating diseases dymyelinating diseases such as diabetic neuropathy, Guillain-Barré Syndrome, chronic demyelinating disease, acute demyelinating polyneuropathy and human immunodeficiency viral demyelinating neuropathy or demyelination caused by trauma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.